Differences in the prevalence of infection between the modified cell lines can be explained by a concomitant impairment of the activation of not only IFITM3 but also IFITM1—this difference was also observed when the cells were infected with influenza virus strain A/PR/8/34(H1N1). This evidence concerns the gene IFITM1 and infection.